1Yoshikawa M, Hatakeyama S, Taniguchi K, et al. 6-Gingesulfonic acid, a new anti-ulcer principle, and gingerglycolipids A, B, and C, three new monoacyldigalactosylglycerols, from zin- giberis rhizoma originating in Taiwan [J]. Chem Pharm Bull (Tokyo), 1992, 40 (8): 2235-2241.
2Ghayur MN, Gilani AH, Afridi MB, et al. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways [J]. Vascul Pharma- col, 2005, 43 (4): 234-241.
3Kim DS, Kim JY. Side-chain length is important for shogaols in protecting neuronal cells from beta-amyloid insult[J]. Bioorg Med Chem Lett, 2004, 14 (51): 1287-1289.
4Kim DS, Kim DS, Oppel MN. Shogaols from Zingiber officinale protect IMR32 human neuroblastoma and normal human umbili- cal vein endothelial ceils from lbeta-amyloid (25-35) insult [J]. Planta Med, 2002, 68 (4): 375-376.
5Kyung KS, Gon JH, Geun KY, et al. 6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury [J]. Eur J Neurosei, 2006, 24 (4): 1042-1052.
6Suekawa M, Aburada M, Hc.soya E. Pharmacological studies on ginger. Ⅲ. Effect of the spinal destruction on (6) -shogaol- induced pressor response in rals [J]. J Pharmaeobiodyn, 1986, 9 (10): 853-860.
7HikinoH, Kiso Y, Kato N, et al. Antihepatotoxic actions of gingerols and diarylheptanoids [J]. J Ethnopharmacol, 1985, 14 (1): 31-39.
8Ling H, Yang H, Tan SH, et al. 6-Shogaoh an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear faetor-κB acti vation [J]. Br J Pharmacol, 20]0, 161 (8): 1763-1777.
9Wu H, Hsieh MC, Lo CY, et al. 6-Shogaol is more effective than 6-gingerol and curcumin in inhibiting 12-O-tetrade- canoylphorbol 13-acetate-induced tumor promotion in mice [J]. Mol Nutr Food Res, 2010, 54 (9): 1296-1306.
10Levy AS, Simon OR. Six-shogaot inhibits production of tumour necrosis factor alpha, interleukin-1 beta and nitric ox- ide from lipopolysaccharide-stimulated RAW 264. 7 macropha- ges [J]. West Indian Med J, 2009, 58 (4): 295-300.
4Zhao Z Z, Liang Z T, Chan K, et al. A unique issue in the standardization of Chinese materia medica:processing[J]. Planta Med, 2010(76):1975.
5Cai B C, Qin K M, Wu H, et al. Chemical mechanism during chinese medicine processing[J]. Prog Chem, 2012(24):637.
6Deng X M,Yu J Y,Zhao M,et al.Quality assessment of crude and processed ginger by high-performance liquid chromatography with diode array detection and mass spectrometry combined with chemometrics[J].J Sep Sci,2015,38(17):2945-2952.
